Type I error and power in noninferiority/equivalence trials with correlated multiple endpoints: An example from vaccine development trials

Journal of Biopharmaceutical Statistics

Volumn 14, Issue 4, 2004, Pages 893-907

  Kong, Lan ^a   Kohberger, Robert C ^b   Koch, Gary G ^c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b WYETH RESEARCH   (United States)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; PNEUMOCOCCUS VACCINE; VACCINE;

ANALYTIC METHOD; ANALYTICAL ERROR; ANTIBODY BLOOD LEVEL; CALCULATION; CORRELATION COEFFICIENT; COVARIANCE; DATA ANALYSIS; DRUG SCREENING; MATHEMATICAL ANALYSIS; MULTIVARIATE ANALYSIS; NORMAL DISTRIBUTION; PERFORMANCE; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; SEROTYPE; SIMULATION; STANDARD; TREATMENT OUTCOME;

ALGORITHMS; ANTIBODIES; CLINICAL TRIALS; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; ENDPOINT DETERMINATION; HUMANS; RESEARCH DESIGN; VACCINES;

EID: 9244234992     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-200035454     Document Type: Review

References (9)

1. Berger, R. L., Hsu, J. (1996). Bioequivalence trials, intersection-union tests, and equivalence confidence sets (with discussion). Statist. Sci. 11:283-319.
2. Blackwelder, W. C. (1982). Proving the null hypothesis in clinical trials. Control Clin. Trials 3:345-353.
3. Dunnett, C. W., Gent, M. (1977). Significance testing to establish equivalence between treatments, with special reference to data in the form of 2 × 2 tables. Biometrics 33:593-602.
4. Giani, G., Finner, H. (1991). Some general results on least favorable parameter configuration with special reference to equivalence testing and the range statistic. J. Statist. Plan. Inference 28:33-47.
5. Hwang, I. K., Morikawa, T. M. (1999). Design issues in noninferiority/equivalence trials. Drug Inf. J. 33:1205-1218.
6. Laska, N. S., Tang, D., Meisner, M. J. (1992). Testing hypothesis about an identified treatment when there are multiple endpoints. J. Am. Statist. Assoc. 87:825-831.
7. Quan, H., Bolognese, J., Yuan, W. (2001). Assessment of equivalence on multiple endpoints. Stat. Med. 20:3159-3173.
8. Weins, B. L., Iglewicz, B. (1999). On testing equivalence of three populations. J. Biopharm. Stat. 9:465-483.
9. Westlake, W. J. (1976). Symmetrical confidence intervals for bioequivalence trials. Biometrics 32:741-744.